Assessment of demand for prenatal diagnostic testing using willingness to pay

Aaron Caughey, A. Eugene Washington, Virginia Gildengorin, Miriam Kuppermann

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the demand for invasive prenatal diagnostic testing (amniocentesis and diorionic villous sampling) in a racially/ethnically diverse group of pregnant women of all ages in the San Francisco Bay Area by using estimates of willingness to pay for these procedures. METHODS: We surveyed 447 women of varying ages, ethnicity, and socioeconomic levels to assess their desire to undergo and willingness to pay for invasive prenatal testing for chromosomal disorders. Each woman was asked what she would be willing to pay for invasive diagnostic testing up to the fall cost of the procedure. We also asked several demographic and attitudinal questions. RESULTS: Overall, 40% of the women indicated an interest in undergoing invasive prenatal diagnostic testing. Women aged 35 years and older were more likely to desire testing as compared with women aged less than 35 years (72% versus 36%, P <.001). Of the women aged less than 35 years who desired testing, 31% indicated that they would be willing to pay the full price of $1,300, whereas 73% were willing to pay a portion of the cost. Maternal age of 35 years or greater (odds ratio [OR] 3.3; 95% confidence interval [CI] 2.0, 5.6) and willingness to have an elective abortion (OR 2.8; 05% CI 1.6, 4.9) were significant predictors of desire to undergo prenatal diagnostic testing after controlling for income, race/ethnicity, and education. Maternal age of 35 years or greater (OR 3.5; 95% CI 1.59, 7.88) and having an income greater than $35,000 (OR 2.3; 95% CI 1.02, 5.26) were significant predictors of willingness to pay the full price of testing. CONCLUSION: A substantial proportion of women of all ages indicate a desire to undergo and a willingness to pay for prenatal diagnostic testing. Variations in willingness to pay are correlated with both socioeconomic and attitudinal differences in addition to age. Guidelines regarding use of prenatal gezietic diagnosis should be expanded to offer testing to all women, not just those deemed at increased risk.

Original languageEnglish (US)
Pages (from-to)539-545
Number of pages7
JournalObstetrics and Gynecology
Volume103
Issue number3
DOIs
StatePublished - Mar 2004
Externally publishedYes

Fingerprint

Odds Ratio
Confidence Intervals
Maternal Age
Chromosome Disorders
Costs and Cost Analysis
Amniocentesis
San Francisco
Prenatal Diagnosis
Pregnant Women
Demography
Guidelines
Education

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Assessment of demand for prenatal diagnostic testing using willingness to pay. / Caughey, Aaron; Washington, A. Eugene; Gildengorin, Virginia; Kuppermann, Miriam.

In: Obstetrics and Gynecology, Vol. 103, No. 3, 03.2004, p. 539-545.

Research output: Contribution to journalArticle

Caughey, Aaron ; Washington, A. Eugene ; Gildengorin, Virginia ; Kuppermann, Miriam. / Assessment of demand for prenatal diagnostic testing using willingness to pay. In: Obstetrics and Gynecology. 2004 ; Vol. 103, No. 3. pp. 539-545.
@article{f5aa27b4cb654a60ad7731f040e2f528,
title = "Assessment of demand for prenatal diagnostic testing using willingness to pay",
abstract = "OBJECTIVE: To investigate the demand for invasive prenatal diagnostic testing (amniocentesis and diorionic villous sampling) in a racially/ethnically diverse group of pregnant women of all ages in the San Francisco Bay Area by using estimates of willingness to pay for these procedures. METHODS: We surveyed 447 women of varying ages, ethnicity, and socioeconomic levels to assess their desire to undergo and willingness to pay for invasive prenatal testing for chromosomal disorders. Each woman was asked what she would be willing to pay for invasive diagnostic testing up to the fall cost of the procedure. We also asked several demographic and attitudinal questions. RESULTS: Overall, 40{\%} of the women indicated an interest in undergoing invasive prenatal diagnostic testing. Women aged 35 years and older were more likely to desire testing as compared with women aged less than 35 years (72{\%} versus 36{\%}, P <.001). Of the women aged less than 35 years who desired testing, 31{\%} indicated that they would be willing to pay the full price of $1,300, whereas 73{\%} were willing to pay a portion of the cost. Maternal age of 35 years or greater (odds ratio [OR] 3.3; 95{\%} confidence interval [CI] 2.0, 5.6) and willingness to have an elective abortion (OR 2.8; 05{\%} CI 1.6, 4.9) were significant predictors of desire to undergo prenatal diagnostic testing after controlling for income, race/ethnicity, and education. Maternal age of 35 years or greater (OR 3.5; 95{\%} CI 1.59, 7.88) and having an income greater than $35,000 (OR 2.3; 95{\%} CI 1.02, 5.26) were significant predictors of willingness to pay the full price of testing. CONCLUSION: A substantial proportion of women of all ages indicate a desire to undergo and a willingness to pay for prenatal diagnostic testing. Variations in willingness to pay are correlated with both socioeconomic and attitudinal differences in addition to age. Guidelines regarding use of prenatal gezietic diagnosis should be expanded to offer testing to all women, not just those deemed at increased risk.",
author = "Aaron Caughey and Washington, {A. Eugene} and Virginia Gildengorin and Miriam Kuppermann",
year = "2004",
month = "3",
doi = "10.1097/01.AOG.0000116212.89556.42",
language = "English (US)",
volume = "103",
pages = "539--545",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Assessment of demand for prenatal diagnostic testing using willingness to pay

AU - Caughey, Aaron

AU - Washington, A. Eugene

AU - Gildengorin, Virginia

AU - Kuppermann, Miriam

PY - 2004/3

Y1 - 2004/3

N2 - OBJECTIVE: To investigate the demand for invasive prenatal diagnostic testing (amniocentesis and diorionic villous sampling) in a racially/ethnically diverse group of pregnant women of all ages in the San Francisco Bay Area by using estimates of willingness to pay for these procedures. METHODS: We surveyed 447 women of varying ages, ethnicity, and socioeconomic levels to assess their desire to undergo and willingness to pay for invasive prenatal testing for chromosomal disorders. Each woman was asked what she would be willing to pay for invasive diagnostic testing up to the fall cost of the procedure. We also asked several demographic and attitudinal questions. RESULTS: Overall, 40% of the women indicated an interest in undergoing invasive prenatal diagnostic testing. Women aged 35 years and older were more likely to desire testing as compared with women aged less than 35 years (72% versus 36%, P <.001). Of the women aged less than 35 years who desired testing, 31% indicated that they would be willing to pay the full price of $1,300, whereas 73% were willing to pay a portion of the cost. Maternal age of 35 years or greater (odds ratio [OR] 3.3; 95% confidence interval [CI] 2.0, 5.6) and willingness to have an elective abortion (OR 2.8; 05% CI 1.6, 4.9) were significant predictors of desire to undergo prenatal diagnostic testing after controlling for income, race/ethnicity, and education. Maternal age of 35 years or greater (OR 3.5; 95% CI 1.59, 7.88) and having an income greater than $35,000 (OR 2.3; 95% CI 1.02, 5.26) were significant predictors of willingness to pay the full price of testing. CONCLUSION: A substantial proportion of women of all ages indicate a desire to undergo and a willingness to pay for prenatal diagnostic testing. Variations in willingness to pay are correlated with both socioeconomic and attitudinal differences in addition to age. Guidelines regarding use of prenatal gezietic diagnosis should be expanded to offer testing to all women, not just those deemed at increased risk.

AB - OBJECTIVE: To investigate the demand for invasive prenatal diagnostic testing (amniocentesis and diorionic villous sampling) in a racially/ethnically diverse group of pregnant women of all ages in the San Francisco Bay Area by using estimates of willingness to pay for these procedures. METHODS: We surveyed 447 women of varying ages, ethnicity, and socioeconomic levels to assess their desire to undergo and willingness to pay for invasive prenatal testing for chromosomal disorders. Each woman was asked what she would be willing to pay for invasive diagnostic testing up to the fall cost of the procedure. We also asked several demographic and attitudinal questions. RESULTS: Overall, 40% of the women indicated an interest in undergoing invasive prenatal diagnostic testing. Women aged 35 years and older were more likely to desire testing as compared with women aged less than 35 years (72% versus 36%, P <.001). Of the women aged less than 35 years who desired testing, 31% indicated that they would be willing to pay the full price of $1,300, whereas 73% were willing to pay a portion of the cost. Maternal age of 35 years or greater (odds ratio [OR] 3.3; 95% confidence interval [CI] 2.0, 5.6) and willingness to have an elective abortion (OR 2.8; 05% CI 1.6, 4.9) were significant predictors of desire to undergo prenatal diagnostic testing after controlling for income, race/ethnicity, and education. Maternal age of 35 years or greater (OR 3.5; 95% CI 1.59, 7.88) and having an income greater than $35,000 (OR 2.3; 95% CI 1.02, 5.26) were significant predictors of willingness to pay the full price of testing. CONCLUSION: A substantial proportion of women of all ages indicate a desire to undergo and a willingness to pay for prenatal diagnostic testing. Variations in willingness to pay are correlated with both socioeconomic and attitudinal differences in addition to age. Guidelines regarding use of prenatal gezietic diagnosis should be expanded to offer testing to all women, not just those deemed at increased risk.

UR - http://www.scopus.com/inward/record.url?scp=1842615101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842615101&partnerID=8YFLogxK

U2 - 10.1097/01.AOG.0000116212.89556.42

DO - 10.1097/01.AOG.0000116212.89556.42

M3 - Article

C2 - 14990419

AN - SCOPUS:1842615101

VL - 103

SP - 539

EP - 545

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -